DOI: https://dx.doi.org/10.18203/2320-1770.ijrcog20175019
Published: 2017-10-28

Randomized comparative study of safety and efficacy of oral and vaginal misoprostol in the termination of second trimester pregnancy at tertiary care institution

Lujimmala S., Anitha E.

Abstract


Background: A prospective randomized study was conducted in 72 pregnant women, with gestational period between 12 and 20 weeks, to compare the efficacy and safety of oral versus vaginal administration of misoprostol for second trimester pregnancy termination. The study was conducted in the Department of Obstetrics and Gynaecology, Government Kilpauk Medical College and Hospital (KMCH), Chennai, South India from November 2012 and November 2013.

Methods: Women aged 18-38 years requesting MTP for maternal reason, foetal congenital anomalies and intrauterine foetal demise were randomly assigned into two groups.  Group A (n=36) had misoprostol orally while the Group B (n=36) received misoprostol by vaginal route. Dosage regimen was similar in both the groups that was 200µg every 4 hrs until the abortion occurred, maximum up to 6 doses. Efficacy included induction to delivery interval and safety included maternal complications and side-effects like nausea, vomiting, diarrhoea, fever and abdominal pain and results were compared.

Results: The percentage of women who delivered was significantly higher in the vaginal group than the oral group (94.44% versus 66.67%, P <0.03018) within 24 hours. The induction to delivery interval and incidence of side-effects were noted.

Conclusions: Vaginal administration of misoprostol resulted in a higher success rate and misoprostol is safe and effective drug for second trimester pregnancy termination.


Keywords


Misoprostol, Oral route, Second trimester pregnancy termination, Vaginal route

Full Text:

PDF

References


Khan ME, Barge S, Kumar N, Almroth S. Abortion in India: current situation and future challenges. In: Pachuri S, Subramaniam S, eds. Implementing a Reproductive Health Agenda in India: The Beginning. 1st ed. New Delhi: Population Council Regional Office; 1998:507-529.

Consortium on National Consensus for Medical Abortion in India. New Delhi: Consortium on National Consensus for Medical Abortion in India. Available at http://www.aiims.edu/aims/events/Gynaewebsite/ma_finalsite/introduction.html. Accessed 3 Dec 2008.

Robert Johnston. Wm. Historical abortion statistics, India. 2013.

Bebbington MW, Kent N, Lim K, Gagnon A, Delisle MF, Tessier F, et al. A randomized controlled trail comparing two protocols for the use of misoprostol in mid-trimester pregnancy termination. Am J Obstet Gynecol. 2002;187:853-7.

Behrashi M, Mahdian M. Vaginal versus oral misoprostol for second-trimester pregnancy termination: a randomized trial. Pak J Biol Sci. 2008;11(21):2505-8.

Jain JK, Mishell DR Jr. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second trimester pregnancy. N Eng J Med. 1994;331:290-3.

Nuutila M, Toivonen J, Ylikorkala O, Halmesmäki E. A comparison between two doses of intra vaginal misoprostol and gemeprost for induction of second trimester abortion. Obstet Gynecol. 1997;90:896-900.

Prachasilpchai N, Russameecharoen K, Borriboonhirunsarn D. Success rate of second-trimester termination of pregnancy using misoprostol. J Med Assoc Thai. 2006;89:1115-9.

Shah SR, Tripathi JB, Suthar HD, Modi KJ, Astik JK, Bhuria DJ. Role of vaginal misoprostol in second trimester termination of pregnancy. J Obstet Gynecol Ind. 2010;60(2):146-8.

El Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone -a randomized comparison between two misoprostol regimens. Hum Reprod. 1995;10:475-8.

Javed L, Malik M, Jamal N, Sheikh S, Farzana F. Mid-trimester termination of pregnancy-comparison of sublingual with vaginal misoprostol. Biomedica. 2004;20:56-9.

Iqbal R, Yaqoob S, Khan F. A comparison of oral and vaginal misoprostol in 2nd trimester termination of pregnancy. JFJMC. 2007;1:70-2.

Dickinson JE, Evans SF. A comparison of oral misoprostol with vaginal misoprostol administration in second trimester pregnancy termination for fetal abnormality. Obstet Gynecol. 2003;101:1294-9.

Kamal R, Parveen F, Mazhar B. Role of misoprostol in vaginal versus double oro vaginal route for termination of pregnancy in mid-trimester pregnancy. Ann Pak Inst Med Sci. 2005;1:196-200.

Wildschut H, Both MI, Medema S, Thomee E, Wildhagen MF, Kapp N. Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev. 2011;19:CD005.